A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving

Psychopharmacology

Volumn 217, Issue 3, 2011, Pages 341-351

  Ray, Lara A ^a   Chin, Pauline F ^a   Heydari, Andia ^a   Miotto, Karen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol craving; Alcoholism; Laboratory; Quetiapine; Subjective intoxication

Indexed keywords

ALCOHOL; PLACEBO; QUETIAPINE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOLISM; ANXIETY; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FEMALE; HUMAN; LIBIDO; MALE; MOOD; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SLEEP; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SYNDROME;

ADULT; AGED; ALCOHOLIC INTOXICATION; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; CUES; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 82955198411     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2287-3     Document Type: Article

References (43)

1. Anton RF, Moak DH, Latham P (1995) The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99
2. Anton RF, Moak DH, Latham PK (1996) The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 53:225-231 (Pubitemid 26085204)
3. Atmaca M, Kuloglu M, Tezcan E (2005) A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. Int J Impot Res 17:201-203 (Pubitemid 40434598)
4. Babiker IE, Cooke PR, Gillett MG (1989) How useful is riboflavin as a tracer of medication compliance? J Behav Med 12:25-38 (Pubitemid 19198951)
5. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B (1992) Types of alcoholics. I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49:599-608
6. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897 (Pubitemid 19008360)
7. Besson M, Belin D, McNamara R, Theobald DE, Castel A, Beckett VL, Crittenden BM, Newman AH, Everitt BJ, Robbins TW, Dalley JW (2010) Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology 35:560-569
8. Bohn MJ, Krahn DD, Staehler BA (1995) Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19:600-606
9. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213 (Pubitemid 19144991)
10. Croissant B, Klein O, Gehrlein L, Kniest A, Hermann D, Diehl A, Mann K (2006) Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series. Eur Psychiatry 21:570-573 (Pubitemid 44855529)
11. Del Boca FK, Kranzler HR, Brown J, Korner PF (1996) Assessment of medication compliance in alcoholics through UVlight detection of a riboflavin tracer. Alcohol Clin Exp Res 20:1412-1417 (Pubitemid 26393943)
12. Erblich J, Earleywine M (1995) Distraction does not impair memory during intoxication: support for the attention-allocation model. J Stud Alcohol 56:444-448
13. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview for DSM-IV Axis I Disorders -Patient edition (SCID-I/P, version 2.0). . Biometrics Research Department, New York State Psychiatric Institute., Biometrics Research Department, New York State Psychiatric Institute
14. Flannery BA, Volpicelli JR, Pettinati HM (1999) Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 23:1289-1295 (Pubitemid 29409341)
15. Guardia J, Roncero C, Galan J et al. (2011) A double-blind, placebocontrolled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcoholdependent patients. Addict Behav
16. Horacek J, Bubenikova-Valesova V, Kopecek M, Palenicek T, Dockery C, Mohr P, Hoschl C (2006) Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20:389-409 (Pubitemid 43763739)
17. Jacobson AF, Goldstein BJ, Dominguez RA, Steinbook RM (1986) Interrater agreement and intraclass reliability measures of SAFTEE in psychopharmacologic clinical trials. Psychopharmacol Bull 22:382-388 (Pubitemid 16043809)
18. Kampman KM, Pettinati HM, Lynch KG, Whittingham T, Macfadden W, Dackis C, Tirado C, Oslin DW, Sparkman T, O'Brien CP (2007) A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 27:344-351 (Pubitemid 47075504)
19. Levine J, Schooler NR (1986) SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 22:343-381 (Pubitemid 16043808)
20. Lindberg N, Tani P, Takala P, Sailas E, Putkonen H, Eronen M, Virkkunen M (2006) Increased deep sleep in a medication-free, detoxified female offender with schizophrenia, alcoholism and a history of attempted homicide: effect of concomitant administration of quetiapine and citalopram. Crim Behav Ment Health 16:60-66 (Pubitemid 46930893)
21. MacKillop J (2006) Factor structure of the alcohol urge questionnaire under neutral conditions and during a cue-elicited urge state. Alcohol Clin Exp Res 30:1315-1321 (Pubitemid 44114682)
22. Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993) Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17:140-146 (Pubitemid 23080981)
23. Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L (2008) Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Hum Psychopharmacol 23:417-424
24. Menon A, Williams RH, Watson S (2006) Increased libido associated with quetiapine. J Psychopharmacol 20:125-127
25. Monnelly EP, Ciraulo DA, Knapp C, LoCastro J, Sepulveda I (2004) Quetiapine for treatment of alcohol dependence. J Clin Psychopharmacol 24:532-535 (Pubitemid 39274208)
26. Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987) Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122-126 (Pubitemid 17085618)
27. Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI, Brown RA, Gordon A, Abrams DB, Niaura RS, Asher MK (2001) Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res 25:1634-1647 (Pubitemid 33104926)
28. Novick D, Haro JM, Perrin E, Suarez D, Texeira JM (2009) Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Eur Neuropsychopharmacol 19:542-550
29. Pezze MA, Dalley JW, Robbins TW (2007) Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 32:273-283 (Pubitemid 46106934)
30. Potvin S, Stip E, Lipp O, Elie R, Mancini-Marie A, Demers MF, Roy MA, Bouchard RH, Gendron A (2006) Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin 22:1277-1285 (Pubitemid 44085579)
31. Ray LA, Hutchison KE (2004) A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28:1789-1795 (Pubitemid 39665194)
32. Ray LA, Meskew-Stacer S, Hutchison KE (2007) The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. J Stud Alcohol Drugs 68:379-384
33. Ray LA, MacKillop J, Leventhal A, Hutchison KE (2009) Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcohol Clin Exp Res 33:2154-2161
34. Ray LA, Heydari A, Zorick T (2010a) Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug Alcohol Rev 29:568-575
35. Ray LA, Hutchison KE, Tartter M (2010b) Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des 16:2149-2158
36. Roberts JS, Anton RF, Latham PK, Moak DH (1999) Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res 23:1484-1491 (Pubitemid 29468445)
37. Sattar SP, Bhatia SC, Petty F (2004) Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci 29:452-457 (Pubitemid 40075716)
38. Schuckit MA (1984) Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41:879-884 (Pubitemid 14026548)
39. Sobell LC, Sobell MB (1980) Convergent validity: an approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers. In: Sobell LC, Sobell MB, Ward E (eds) Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. Pergamon Press, Elmsford, pp 177-183
40. Stedman M, Pettinati HM, Brown ES, Kotz M, Calabrese JR, Raines S (2010) A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. Alcohol Clin Exp Res 34:1822-1831
41. Stritzke WG, Patrick CJ, Lang AR (1995) Alcohol and human emotion: a multidimensional analysis incorporating startle-probe methodology. J Abnorm Psychol 104:114-122
42. Van den Eynde F, Senturk V, Naudts K, Vogels C, Bernagie K, Thas O, van Heeringen C, Audenaert K (2008) Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacol 28:147-155 (Pubitemid 351417119)
43. Wiers RW (2008) Alcohol and drug expectancies as anticipated changes in affect: negative reinforcement is not sedation. Subst Use Misuse 43:429-444 (Pubitemid 351448736)